Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSilverwood Brands Plc Regulatory News (SLWD.PL)

Share Price Information for Silverwood Brands Plc (SLWD.PL)

Share Price is delayed by 15 minutes
Get Live Data
10.00    0.00 (0.00%)
Bid:
5.00
Ask:
15.00
Spread: 10.00 (200.00%)
Market Cap: £4.35m
SLWD.PL Live PriceLast checked at - Aquis Stock Exchange

Intraday Silverwood Brands Plc Share Chart

Trading Update

1 May 2024 07:00

RNS Number : 6814M
Silverwood Brands PLC
01 May 2024
 

1 May 2024

 

Silverwood Brands Plc

("Silverwood" or the "Company"; together with its subsidiaries, the "Group)

 

Trading Update

 

Silverwood Brands plc (Aquis: SLWD), a holding company established to invest primarily in branded consumer businesses, is pleased to announce a trading update for the year ended 31 December 2023 and for the quarter ended 31 March 2024. The Company expects to publish its audited results for the year ended 31 December2023 by the end of June 2024.

 

2023 - Business Review

 

For this update we want to provide an overview of the year. This is made with the obvious caveat that we do not yet have the final audited figures available.

 

The year saw the first full year of trading for our existing brand portfolio of Balmonds, Nailberry and Sonotas (comprising SteamCream and Cigarro).

 

We would note that our underlying brands performed in line with our expectations - that is, we do not expect a simple tidy linear pattern when growing these smaller brands. On a month to month basis, even a year to year basis, we expect a bumpy ride. However, over the longer term we expect a picture of profitable growth.

 

Our teams remain committed to the task of delivering that growth and we continue to be impressed by their efforts.

 

Balmonds

As mentioned in our report for the previous financial year, "Balmonds enjoyed some well-placed press coverage during the year which gave a pleasant boost to sales. This may prove difficult to replicate…."

 

Annoyingly we were unable to replicate the boost we enjoyed in 2022 and sales fell by approximately 20% on a year on year basis. We would note that 2023 still achieved a substantial uplift against 2021, which is in line with the bumpy growth patterns we expect and represents strong growth over the two year period.

 

The reduced sales amount and investments made in product development and to launch the brand in new markets is likely to result in a loss for the year at Balmonds.

 

Nailberry

Nailberry continues to attract new customers and open new sales channels. This has resulted in sales growth over the prior year.

 

We congratulate the Nailberry team on this performance.

 

Sonotas

Sonotas operates the SteamCream, Cigarro and Nailberry brands in Japan. SteamCream worked on its channel mix of wholesale, events and direct to consumer digital sales during this period, moving away from owned retail. Sales have begun to improve, and operating margins grew modestly. Cigarro's rapid growth slowed in 2023 with China supply chain issues affecting packaging sourcing; problems have since been resolved. Nailberry launched in Q4 2023, focused on pop-up events in premium locations such as Isetan department stores.

 

Lush

As noted in previous announcements about this transaction, we were very disappointed with the reaction of the Lush management team to our position, and we have taken the pragmatic approach of withdrawing from the acquisition due to the aggressive stance adopted by Lush. Our previous announcements covered the details of this.

 

We have now effected an unwinding of the transaction via a capital reduction which was approved by the court on 16 April 2024 and completed on 30 April 2024.

 

The attempted transaction consumed a huge amount of management time and focus, along with associated costs. Much of this fee cost was reimbursed by Andrew Gerrie and Alison Hawksley. We now wish them good luck in their endeavours to achieve a sale of their Lush shares.

 

Financing

We are fortunate to have Castlenau Group Limited ("Castelnau") as a shareholder, and one that shares our long term view on building businesses.

 

Following the year end, Castlenau agreed to convert the majority of its loan position into ordinary shares in the Company. This was completed on 29 January 2024 at a price of 54p per share.

 

At the same time, the Company completed a £1.0 million subscription from Andrew Gerrie, also at 54p per share, and Silver Americum Limited, a company in which Mr Gerrie and his wife each hold separate 20% interests, agreed to provide an unsecured convertible loan of £0.5 million to the Company.

 

Group

Group numbers are expected to show a consolidated pre-tax loss for the 2023 financial year.

 

Q1 2024 - Trading Update

 

Trading in our brands since our December year end has been as expected.

 

Balmonds

The long term focus of growing the business has continued at Balmonds.

 

Whilst a rebranding project has proved disruptive, we believe it will help build sales in the long term. The new look and packaging have been well received by those customers who have seen it and also by buyers from retail chains we are targeting. Now we need to convert that response to sales.

 

Additional work has gone in to supporting a medical device license application for Balmonds' Skin Salvation balm. If granted, this will allow for more effective marketing around the benefits of this product.

 

Nailberry

We continue to attract new customers to Nailberry, and the brand is performing in line with our expectations.

 

Sonotas

Sonotas' sales continue to reflect the exit from its retail business, with the closure of 5 stores, in April 2023. However, other SteamCream channels grew significantly in this period, particularly in online and digital channels, wholesale sales and events sales. Sonotas' profitability for the quarter was, however, impacted by the transaction costs associated with the purchase of the Japanese cosmetic OEM manufacturer Cosme Science and its subsidiary Dr. Baeltz, which we completed on 29 March 2024. The details of this were noted in our announcement on 2 April 2024.

 

Cosme Science provides us with a wonderful production base to support our Asian ambitions. The business started in 1984 and now provides formulation, production and distribution capabilities from a modern warehouse/production base of 6,700 sq. metres in Tokyo.

 

The business has an IP catalogue of over 2,000 product formulae and employs over 100 full time equivalent staff including 6 research and development professionals.

 

We also acquired a small skincare brand, Dr Baeltz, as part of the Cosme Science purchase.

 

Group

As previously noted, our cost base here remains very lean, and we continue to focus on limiting expenditure wherever possible. However, we will increasingly need to address some key functions which are currently not paid for.

 

Moreover, whilst we have greatly reduced our interest expense and hope to reduce our legal expenses even further, we do expect management remuneration to increase from a current position of nil, to rates which are more reflective of market norms.

 

Future Prospects

 

Silverwood is not immune to the headwinds battering global markets, but we believe that our commitment and experience will enable us to prosper over the longer term. We are resolutely focused on enabling our existing brands to deliver their full potential, whilst continuously reviewing complimentary brand opportunities when we find them.

 

Overall, therefore, your Directors view the future with confidence.

 

Shareholder online meeting

 

We are planning to hold a shareholder webinar following the announcement of our 2023 full year results with a focus on Q&A with the management team. Further details will be announced in due course.

 

--Ends--

 

Silverwood Brands Plc

Andrew Gerrie

Paul Hodgins

 

info@silverwoodbrands.com 

Peterhouse Capital Limited (Aquis Corporate Adviser)

Mark Anwyl

Narisha Ragoonanthun

Brefo Gyasi

 

+44 (0)20 7469 0930

About Silverwood Brands PLC

Silverwood Brands PLC is a leader in the health and beauty industry, committed to developing and marketing high-quality products that meet the diverse needs of consumers worldwide. Through strategic acquisitions and organic growth, Silverwood Brands continues to enhance its portfolio and global reach, ensuring a strong position in the competitive health and beauty market.

Market Abuse Regulation (MAR) Disclosure

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation EU 596/2014 as it forms part of retained EU law (as defined in the European Union (Withdrawal) Act 2018).

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXURRNRSBUSOAR
Date   Source Headline
14th May 202610:21 amRNSResult of General Meeting
20th Apr 20267:01 amRNSUnaudited Interim Results
20th Apr 20267:00 amRNSAudited Final Results
31st Dec 20259:58 amRNSDelay to Publication of Audited Results
31st Dec 20259:58 amRNSDelay to Publication of Audited Results
15th Dec 20259:16 amRNSResult of Annual General Meeting
21st Nov 202511:31 amRNSBoard Change and Notice of AGM
3rd Oct 20253:00 pmRNSAppointment of Aquis Corporate Adviser
16th Jul 20254:33 pmRNSDeferred Consideration; Director/PDMR Shareholding
3rd Apr 202512:32 pmRNSLeading Balmonds product now available at Boots
31st Mar 20252:17 pmRNSUnaudited Interim Results to 31 December 2024
2nd Dec 20243:32 pmRNSDirector/PDMR Shareholding
29th Oct 20242:35 pmRNSChange of Accounting Reference Date
10th Oct 20242:47 pmRNSDirector/PDMR Shareholding
8th Oct 20247:00 amRNSChange of Registered Office Address
30th Sep 20242:06 pmRNSUnaudited Interim Results
25th Jul 20249:18 amRNSResult of General Meeting
1st Jul 202411:33 amRNSProvision of Annual Report; General Meeting Notice
28th Jun 20245:10 pmRNSAnnual report For the year ended 31 December 2023
28th Jun 202412:08 pmRNSResult of AGM
31st May 20244:31 pmRNSNotice of AGM
15th May 20243:46 pmRNSDirector/PDMR Shareholding - Correction
14th May 202412:33 pmRNSDirector/PDMR Shareholding
7th May 202412:04 pmRNSDirector/PDMR Shareholding
1st May 202411:57 amRNSHolding in Company
1st May 20247:00 amRNSTrading Update
30th Apr 202412:16 pmRNSCapital Reduction complete; Restoration of Trading
19th Apr 20247:00 amRNSDelayed Restoration of Trading
2nd Apr 20247:00 amRNSAcquisition of Cosme Science Corporation
8th Mar 202411:47 amRNSResult of General Meeting
1st Mar 20247:00 amRNSAcquisition of Cosme Science Corporation
20th Feb 20244:54 pmRNSProposed Capital Reduction and Notice of GM
31st Jan 20243:22 pmRNSTotal Voting Rights
29th Jan 20241:30 pmRNSTrading Update
29th Jan 20241:30 pmRNSUnaudited Interim Results
10th Jan 20247:00 amRNSSettlement Deed
13th Oct 20231:12 pmRNSLoan Extension and Waiver
9th Oct 20233:54 pmRNSUpdate on Legal Proceedings
2nd Oct 20237:00 amRNSDirectorate Change
2nd Oct 20237:00 amRNSUpdate on Defence Extension; Temporary Suspension
21st Sep 20237:00 amRNSChange of Corporate Adviser
19th Sep 202311:05 amRNSUpdate on Defence Extension
14th Aug 20237:00 amRNSAcknowledgement of Service & Defence Extension
27th Jul 20237:00 amRNSLush transaction update; legal proceedings notice
26th Jul 202310:21 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.